Neuromonics Tinnitus Treatments are the only FDA approved, clinically proven aid for Tinnitus to successfully reduce tinnitus and ear noise disturbance by up to 92% of suitable candidates of more than 70%.
Neuromonics Haven is a tinnitus management tool targeting to provide immediate relief for the tinnitus patients while listening to the device.
Patients are assessed using a questionnaire called the TRQ (Tinnitus Reaction Questionnaire), which is used to gauge the degree of one's tinnitus disturbance - Patients whose score is 35 or below are deemed to be suitable for this product.
Fully customised based on patient’s tinnitus assessment results, Haven uses phase one of the Neuromonics treatment to provide sense of control by delivering a customized signal designed for maximum interaction with the tinnitus perception. This interaction provides an almost immediate sense of control and relief for the tinnitus patient.
For patients who are unable to follow Oasis protocol but is disturbed enough by tinnitus that a more specific threshold programming could prove to be beneficial in order to address their tinnitus disturbance as compared to the semi customized program in Sanctuary. Like Sanctuary, Haven can also be for individuals who with a complaint of tinnitus that are seeking a management program as opposed to a treatment protocol.
It is also suitable for patients who experience difficulty before bed and during quiet times; such as while reading or working on a computer. Also, if concentration is a problem, this protocol is appropriate as Haven is designed to provide relief for patients during times when their tinnitus is disturbing.
Tinnitus Reaction Questionnaire